(239 days)
The subject devices are intended to be placed in the mouth for use as an anchor in orthodontic procedures.
The Bollard Miniplate Skeletal Anchorage System provides a fixed anchorage point for the attachment of orthodontic appliances to facilitate orthodontic movement of teeth. Small stationary points connected to bone inside the mouth allow connection of wire, elastic, or other hardware.
The Bollard Miniplate Skeletal Anchorage System includes Commercially Pure Titanium miniplates fixed by miniscrews to the cortical bone. After insertion by the surgeon the miniplates are completely covered by soft tissue. The miniplates and miniscrews are sold sterile and are sterilized using Gamma Radiation per ISO 11137-1.
The bone anchor consists of a miniplate (M) with 2 or 3 holes, a round connecting bar (C), and a fixation unit (F) with a blocking screw (S). The miniplate is fixed to the bone by self-tapping or selfdrilling screws. The fixation unit contains 2 slots with a diameter of 0.045" (1.1mm). A square connecting wire with a maximum size of 0.032x0.032" can be inserted and tightly fixed by the blocking screw.
The Bollard miniplates are also offered with a hook. The Bollard with hook is smaller than the original model and contains a tube with section 0.020"x0.020". The hook can affix directly to elastics or coil springs.
The subject devices are used with standard instrumentation for orthodontic surgery including pliers, punches, screwdrivers, burrs, and grasping or holding instruments.
The provided text is a 510(k) Summary for the TITA-LINK Bollard Miniplate Skeletal Anchorage System. It describes the device, its indications for use, and its substantial equivalence to predicate devices. However, it does not contain information about acceptance criteria, a study proving device performance against those criteria, or details regarding sample sizes, ground truth establishment, or expert involvement for a study of the device.
The document states: "The subject device is composed of well characterized and biocompatible material that meets applicable standards." and "We believe the changes are minor and conclude that the subject devices are as safe and effective as the predicate device." This indicates that the approval was based on demonstrating substantial equivalence to a legally marketed predicate device, rather than through a de novo performance study with specific acceptance criteria.
Therefore, I cannot populate the requested table or answer the specific questions about acceptance criteria, study details, sample sizes, expert involvement, or ground truth, as this information is not present in the provided text.
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.